Versigent CEO granted 489 dividend rights

Versigent PLC’s CEO received a small dividend-equivalent award tied to existing restricted stock units, increasing his derivative-based exposure to ordinary shares.

Rhea-AI Filing Summary

Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Liotine Joseph T. reported acquisition or exercise transactions in this Form 4 filing.

Versigent PLC (VGNT) reported that CEO and Director Joseph T. Liotine received an automatic grant of 489.229 dividend equivalent rights on September 18, 2026. These rights accrued on previously granted restricted stock units due to a dividend and are economically equivalent to 489.229 ordinary shares, vesting on the same schedule as the underlying units. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 489.229 shares

Grant/Award 1 txn

Insider Liotine Joseph T.

Role CEO and Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	489.229	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 489.229 contracts (Direct)

Footnotes (1)

1. F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

Key Figures

Dividend equivalent rights granted: 489.229 rights Dividend equivalent rights after transaction: 489.229 rights Grant price per dividend equivalent right: $0.00 per right +2 more

5 metrics

Dividend equivalent rights granted 489.229 rights Grant on September 18, 2026 to CEO and Director Joseph T. Liotine

Dividend equivalent rights after transaction 489.229 rights Total derivative securities beneficially owned following the acquisition

Grant price per dividend equivalent right $0.00 per right Reported transaction price for the September 18, 2026 acquisition

Underlying ordinary shares 489.229 shares Each dividend equivalent right is the economic equivalent of one ordinary share

Rule 10b5-1 plan status No Rule 10b5-1 plan reported Affirmation checkbox for Rule 10b5-1 is not selected

Key Terms

Dividend Equivalent Rights, restricted stock units, ordinary shares

3 terms

Dividend Equivalent Rights financial

"The dividend equivalent rights accrued on grants of restricted stock units"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock units financial

"accrued on grants of restricted stock units as a result of a dividend"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

ordinary shares financial

"Each dividend equivalent right is the economic equivalent of one share"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VGNT report for Joseph T. Liotine?

Versigent PLC reported that CEO and Director Joseph T. Liotine received an award of 489.229 dividend equivalent rights on September 18, 2026, tied to prior restricted stock unit grants and economically equivalent to the same number of ordinary shares.

How many dividend equivalent rights were granted in this VGNT Form 4?

The filing reports a grant of 489.229 dividend equivalent rights. Each right is the economic equivalent of one ordinary share of Versigent PLC, and the rights vest on the same schedule as the related restricted stock units.

What is the value and vesting schedule of the VGNT dividend equivalent rights?

The dividend equivalent rights were granted at a reported price of $0.00 per right and each right is economically equivalent to one ordinary share. They vest on the same schedule as the underlying restricted stock units to which they relate.

Why were dividend equivalent rights granted to the VGNT CEO?

The filing states that the dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by Versigent PLC, effectively crediting the CEO with additional rights tied to that dividend on his existing RSUs.

Were the VGNT CEO’s dividend equivalent rights acquired under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not checked, and there is no footnote stating the grant was made under a trading plan; the award results from a dividend declared and paid on existing RSUs.

What are the CEO’s holdings of these dividend equivalent rights after the VGNT transaction?

After the reported transaction, Joseph T. Liotine holds 489.229 dividend equivalent rights directly, as shown by the total derivative securities beneficially owned following the acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:06 PM Accepted by SEC EDGAR 09/22/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liotine Joseph T.

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/18/2026		A		489.229		(1)	(1)	Ordinary Shares	489.229	$0.00	489.229	D

Explanation of Responses:

1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

	/s/ Janis N. Acosta, Attorney-in-fact for Joseph T. Liotine	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)